AzTrials
AzTrials

Acute PancreatitisFCMSAPNCT01321060

Fluid Collections Management in Severe Acute Pancreatitis

A study testing Aspiration, Catheter drainage and Conservative treatment in people with Acute Pancreatitis and Acute Pancreatic Fluid Collection, run by Nanjing University School of Medicine at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Acute fluid collections is common in patients with severe acute pancreatitis (SAP). But the treatment for this is controversial. In this study, the investigators aim to evaluate the different effects of three different treatment protocols which is repeated aspiration, continuous catheter drainage and conservative… Read more about this study

Who is it for?
Ages 18 to 70 years
What is being tested?
Aspiration, Catheter drainage and Conservative treatment
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
87 participants
Where
1 siteChina
Study dates
Jan 2011to Dec 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Symptoms and signs of acute pancreatitis according to Atlanta criteria and if pancreatic or/and peripancreatic fluid collections were confirmed by ultrasound and computed tomography examination
  • CT density < 30Hu
  • Within 7 days from the onset of the disease
  • Available approach for percutaneous penetrate

Who cannot join

  • Pregnant pancreatitis
  • Receiving surgery or aspiration before;need of early surgery
  • Infected fluid collection

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • Department of SICU, Research Institute of General Surgery Jinling Hospital,

    Nanjing, Jiangsu, 210002

    Weiqin Li, Dr, +86-025-80860066, kkb9832@gmail.com

    Weiqin Li, Dr

    Recruiting

Other trials in China

About this study

Official title: Management of Sterile Fluid Collections in Patients With Severe Acute Pancreatitis:a Randomized Controlled Trial

Acute fluid collections is common in patients with severe acute pancreatitis (SAP). But the treatment for this is controversial. In this study, the investigators aim to evaluate the different effects of three different treatment protocols which is repeated aspiration, continuous catheter drainage and conservative treatment. The investigators suppose repeated aspiration could not only solve acute fluid collections, but also lower the rate of pancreatic infection.

Being tested
Aspiration, Catheter drainage, Conservative treatment
Keywords
severe acute pancreatitis, acute fluid collection, catheter drainage, repeated aspiration
Medical subject headings
Pancreatitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AspirationProcedure or surgery

  • Catheter drainageProcedure or surgery

  • Conservative treatmentDrug

    Including antibiotics,somatostatin, proton pump inhibitors and sufficient fluid resuscitation

Study groups in NCT01321060
Study groupRoleWhat they receive
Conservative treatmentActive comparatorConservative treatment group with only drugs.
Receives: Drug: Conservative treatment
Continuous catheter drainageExperimentalOnce the diameter of the fluid collection is more than 6cm, continuous catheter drainage will be applied.
Receives: Procedure: Catheter drainage
Repeated aspirationExperimentalOnce the diameter of the fluid collection is more than 6cm, aspiration is applied and draw the tube out immediately after aspiration.
Receives: Procedure: Aspiration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pancreatic infection

    Measured: 28 days

  2. mortality

    Measured: 28 days

Secondary outcomes (7)
  1. inflammation parameters

    Measured: 28 days

  2. intra abdominal pressure

    Measured: 28 days

  3. complications

    intestinal fistula , major bleeding, etc.

    Measured: 28 days

  4. ICU duration

    Measured: day one until discharge

  5. hospital duration

    Measured: day one until discharge

  6. SIRS

    Measured: 28 days

  7. MODS

    Measured: 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Mar 2011 (estimated)
  2. Study startJan 2011
  3. Primary completionDec 2012 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
87 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01321060
Sponsor's protocol ID
RIGS
Acronym
FCMSAP
Status last verified
Jan 2011
First submitted
22 Mar 2011
Last updated
19 Jun 2012
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Aspiration, Catheter drainage and Conservative treatment in people with Acute Pancreatitis and Acute Pancreatic Fluid Collection, run by Nanjing University School of Medicine at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Jun 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Weiqin Li, Dr (+86-025-80860066, kkb9832@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pancreatic infection (time frame: 28 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jun 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in